Source: Clinical Chemistry and Laboratory Medicine. Unidades: ICB, FCF, FM
Subjects: LIPOPROTEÍNAS LDL, HIV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Joel da et al. Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors. Clinical Chemistry and Laboratory Medicine, v. 51, n. 2, p. 371-378, 2013Tradução . . Disponível em: https://doi.org/10.1515/cclm-2012-0225. Acesso em: 15 nov. 2024.APA
Cunha, J. da, Maselli, L. M. F., Treitinger, A., Monteiro, A. M., Gidlund, M. A., Maranhão, R. C., et al. (2013). Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors. Clinical Chemistry and Laboratory Medicine, 51( 2), 371-378. doi:10.1515/cclm-2012-0225NLM
Cunha J da, Maselli LMF, Treitinger A, Monteiro AM, Gidlund MA, Maranhão RC, Spada C, Bydlowski SP. Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors [Internet]. Clinical Chemistry and Laboratory Medicine. 2013 ; 51( 2): 371-378.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1515/cclm-2012-0225Vancouver
Cunha J da, Maselli LMF, Treitinger A, Monteiro AM, Gidlund MA, Maranhão RC, Spada C, Bydlowski SP. Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors [Internet]. Clinical Chemistry and Laboratory Medicine. 2013 ; 51( 2): 371-378.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1515/cclm-2012-0225